DBV Technologies S.A.

DBVT Nasdaq CIK: 0001613780

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation France
Business Address 107 AVENUE DE LA REPUBLIQUE, CHATILLON, I0, 92320
Mailing Address 107 AVENUE DE LA REPUBLIQUE, CHATILLON, I0, 92320
Phone 33(0)155427878
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2024

$140.19M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 3, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
8-K Current report of material events January 20, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 14, 2026 View on SEC
4 Insider stock transaction report January 14, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 8, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 7, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 5, 2026 View on SEC

Insider Trading

STRONG SELL 2 insiders 6 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.